Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences? Irmgard TegederGerd Geisslinger Review 04 April 2006 Pages: 1 - 17
Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine Denise G. Hemmings Editorial 29 March 2006 Pages: 18 - 29
Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat Sung-Kyung RyuDuck Sun AhnYoung-Ho Lee Original Article 07 March 2006 Pages: 30 - 36
Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine Claudia CzyborraAngela BischoffMartin C. Michel Original Article 07 March 2006 Pages: 37 - 44
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin’s cholesterol lowering capabilities and basal sterol serum levels Thomas GerloffMelanie SchaeferKlaus von Bergmann Original Article 28 March 2006 Pages: 45 - 50
Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats Carmelo MuiàEmanuela MazzonSalvatore Cuzzocrea Original Article 28 March 2006 Pages: 51 - 59
β2-Adrenergic stimulation is involved in the contractile dysfunction of the stunned heart Leticia VittoneMatilde SaidAlicia Mattiazzi Original Article 31 March 2006 Pages: 60 - 70
Impairment of endothelium- and nerve-mediated relaxation responses in the cavernosal smooth muscle of experimentally diabetic rabbits: role of weight loss and duration of diabetes Nihan Burul BozkurtCan Pekiner Original Article 30 March 2006 Pages: 71 - 78
Effect of chronic treatment with perazine on lipopolysaccharide-induced interleukin-1β levels in the rat brain Ewa ObuchowiczAgnieszka MarcinowskaZbigniew S. Herman Short communication 01 April 2006 Pages: 79 - 84
L-364,373 fails to activate the slow delayed rectifier K+ current in canine ventricular cardiomyocytes János MagyarBalázs HorváthPéter P. Nánási Short Communication 17 March 2006 Pages: 85 - 90